Abstract:Terminal differentiation of B cells depends on two interconnected survival pathways, elicited by the B-cell receptor (BCR) and the BAFF receptor (BAFF-R), respectively. Loss of either signaling pathway arrests B-cell development. Although BCR-dependent survival depends mainly on the activation of the v-AKT murine thymoma viral oncogene homolog 1 (AKT)/PI3-kinase network, BAFF/BAFF-R-mediated survival engages non-canonical NF-κB signaling as well as MAPK/extracellular-signal regulated kinase and AKT/PI3-kinase modules to allow proper B-cell development. Plasma cell survival, however, is independent of BAFF-R and regulated by APRIL that signals NF-κB activation via alternative receptors, that is, transmembrane activator and CAML interactor (TACI) or B-cell maturation (BCMA). All these complex signaling events are believed to secure survival by increased expression of anti-apoptotic B-cell lymphoma 2 (Bcl2) family proteins in developing and mature B cells. Curiously, how lack of BAFF- or APRIL-mediated signaling triggers B-cell apoptosis remains largely unexplored. Here, we show that two pro-apoptotic members of the ‘Bcl2 homology domain 3-only’ subgroup of the Bcl2 family, Bcl2 interacting mediator of cell death (Bim) and Bcl2 modifying factor (Bmf), mediate apoptosis in the context of TACI-Ig overexpression that effectively neutralizes BAFF as well as APRIL. Surprisingly, although Bcl2 overexpression triggers B-cell hyperplasia exceeding the one observed in Bim−/−Bmf−/− mice, Bcl2 transgenic B cells remain susceptible to the effects of TACI-Ig expression in vivo, leading to ameliorated pathology in Vav-Bcl2 transgenic mice. Together, our findings shed new light on the molecular machinery restricting B-cell survival during development, normal homeostasis and under pathological conditions. Our data further suggest that Bcl2 antagonists might improve the potency of BAFF/APRIL-depletion strategies in B-cell-driven pathologies.

B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1

Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation

The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.

BAP1 depletion in human B‐lymphoblast cells affects the production of innate immune cytokines and chemokines

BAP31 Plays an Essential Role in Mouse B Cell Development via Regulation of BCR Signaling

Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1

Glutamylation of Deubiquitinase BAP1 Controls Self-Renewal of Hematopoietic Stem Cells and Hematopoiesis

Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity

Deubiquitinating Enzyme BAP1 is Involved in the Formation and Maintenance of the Diapause Embryos of Artemia

Epigenetic Regulation of Antibody Responses by the Histone H2A Deubiquitinase MYSM1.

MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer

B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation

The Role Of Ubiquitinase In B Cell Development And Function

BAP1 deubiquitinase is a potent repressor of fetal hemoglobin biosynthesis

B cell Sirt1 deacetylates histone and non-histone proteins for epigenetic modulation of AID expression and the antibody response

BAP31 is Involved in T Cell Activation Through TCR Signal Pathways

Deficiency of Bim in Dendritic Cells Contributes to Overactivation of Lymphocytes and Autoimmunity.

Negative regulation of Activation-Induced Cytidine Deaminase gene transcription in developing B cells by a PU.1-interacting intronic region

Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice

Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response

Bach2 Regulates B Cell Survival to Maintain Germinal Centers and Promote B Cell Memory